Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Whelan

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
BMC Medical Research Methodology|April 19, 2015
Novel participatory methods of involving patients in research: naming and branding a longitudinal cohort study, BRIGHTLIGHTRachel M Taylor, Jasjeet Mohain, Faith Gibson, et al.
Oncology Research and Treatment|June 15, 2018
Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous DifferentiationBaljinder S Dhinsa, Mariagrazia DeLisa, Rob Pollock, et al.
Pediatric Blood & Cancer|November 11, 2009
The role of interferons in the treatment of osteosarcomaJeremy Whelan, Daniel Patterson, Martha Perisoglou, et al.
Oral Oncology|January 23, 2017
Head and neck sarcomas: A single institute seriesLeandros-Vassilios Vassiliou, Bagrat Lalabekyan, Amrita Jay, et al.
Therapeutic Drug Monitoring|November 23, 2011
A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcomaÅsa M Johansson, Nicola Hill, Martha Perisoglou, et al.
Statistical Methods in Medical Research|June 20, 2018
Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensityCarlo Lancia, Cristian Spitoni, Jakob Anninga, et al.
International Journal of Cancer|September 14, 2011
Incidence and survival of malignant bone sarcomas in England 1979-2007Jeremy Whelan, Anne McTiernan, Nicola Cooper, et al.
Molecular Cancer Therapeutics|December 24, 2005
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654AlaSean R McLean, Mali Gana-Weisz, Basil Hartzoulakis, et al.
The Lancet. Child & Adolescent Health|March 6, 2018
Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohortAnnie Herbert, Georgios Lyratzopoulos, Jeremy Whelan, et al.
Clinical Sarcoma Research|September 25, 2012
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell SarcomasJeremy Whelan, Atia Khan, Anand Sharma, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
BMC Medical Research Methodology|April 19, 2015
Novel participatory methods of involving patients in research: naming and branding a longitudinal cohort study, BRIGHTLIGHTRachel M Taylor, Jasjeet Mohain, Faith Gibson, et al.
Oncology Research and Treatment|June 15, 2018
Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous DifferentiationBaljinder S Dhinsa, Mariagrazia DeLisa, Rob Pollock, et al.
Pediatric Blood & Cancer|November 11, 2009
The role of interferons in the treatment of osteosarcomaJeremy Whelan, Daniel Patterson, Martha Perisoglou, et al.
Oral Oncology|January 23, 2017
Head and neck sarcomas: A single institute seriesLeandros-Vassilios Vassiliou, Bagrat Lalabekyan, Amrita Jay, et al.
Therapeutic Drug Monitoring|November 23, 2011
A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcomaÅsa M Johansson, Nicola Hill, Martha Perisoglou, et al.
Statistical Methods in Medical Research|June 20, 2018
Marginal structural models with dose-delay joint-exposure for assessing variations to chemotherapy intensityCarlo Lancia, Cristian Spitoni, Jakob Anninga, et al.
International Journal of Cancer|September 14, 2011
Incidence and survival of malignant bone sarcomas in England 1979-2007Jeremy Whelan, Anne McTiernan, Nicola Cooper, et al.
Molecular Cancer Therapeutics|December 24, 2005
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654AlaSean R McLean, Mali Gana-Weisz, Basil Hartzoulakis, et al.
The Lancet. Child & Adolescent Health|March 6, 2018
Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohortAnnie Herbert, Georgios Lyratzopoulos, Jeremy Whelan, et al.
Clinical Sarcoma Research|September 25, 2012
Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell SarcomasJeremy Whelan, Atia Khan, Anand Sharma, et al.
Pageof 9